211 studies found for:    abacavir OR Abacavir/ Lamivudina/ Zidovudina [TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Completed
Has Results
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Condition: HIV Infection
Interventions: Other: Intervention 1: PK assessment while on Twice Daily Abacavir;   Other: Intervention 2: PK assessment while on Once Daily Abacavir
2 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
3 Completed Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
Condition: Psoriasis
Interventions: Drug: Prurisol;   Drug: Ziagen
4 Active, not recruiting Tenofovir Abacavir Platelet Activation Study
Condition: HIV
Interventions: Drug: abacavir (600 mg QD);   Drug: tenofovir (245 mg QD)
5 Completed Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
Condition: HIV
Interventions: Drug: Abacavir;   Drug: Darunavir/ritonavir;   Drug: Raltegravir
6 Completed Determining the Effect of Abacavir on Platelet Activation
Conditions: HIV;   Cardiovascular Disease
Intervention: Drug: Abacavir
7 Completed
Has Results
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
Condition: Human Immunodeficiency Virus
Interventions: Other: Clinically Driven Monitoring (CDM);   Other: Laboratory plus Clinical Monitoring (LCM);   Drug: Arm A: ABC+3TC+NNRTI;   Drug: Arm B: ZDV+ABC+3TC+NNRTI->ABC+3TC+NNRTI maintenance;   Drug: Arm C: ZDV+ABC+3TC+NNRTI->ZDV+ABC+3TC maintenance;   Drug: Once-daily ABC+3TC;   Drug: Twice-daily ABC+3TC;   Drug: Continued cotrimoxazole prophylaxis;   Other: Stopped cotrimoxazole prophylaxis
8 Completed Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density
Condition: HIV
Intervention: Drug: Switch from tenofovir to abacavir
9 Completed ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
10 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
11 Completed Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
12 Active, not recruiting
Has Results
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: Dolutegravir;   Drug: Atripla;   Drug: Abacavir/Lamivudine;   Drug: Abacavir/Lamivudine Placebo;   Drug: Dolutegravir placebo;   Drug: Atripla placebo
13 Terminated Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Amprenavir;   Drug: Abacavir
14 Completed Abacavir and Lamivudine PK in Children
Condition: HIV
Interventions: Drug: abacavir;   Drug: 3TC
15 Completed Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: Abacavir+lamivudine
16 Recruiting SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over
Condition: HIV
Intervention: Drug: Triumeq
17 Completed
Has Results
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
18 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
19 Unknown  Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment
Condition: Hepatitis C
Interventions: Other: Ribavrin;   Drug: Abacavir plus Ribavirin
20 Recruiting Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Conditions: HIV;   Acute HIV Infection
Intervention: Drug: DTG/3TC/ABC FDC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years